Loading company…
Riskpilot
← Back to search
Sign in
Get full access
OXIRA XR AS
AS
Active
Org 926419919
Isdamveien 24A, 3083 Holmestrand
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2021
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 373K
EBITDA margin
42.5%
+1448% vs 2024
Equity ratio
26.9%
Financial strength
Net profit 2025
NOK 132K
+1154% vs 2024
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 373K
—
EBITDA
NOK 159K
+1448%
Net profit
NOK 132K
+1154%
Total assets
NOK 463K
+1158210%
Equity
NOK 125K
+1876%
Employees
0
—
Company information
Legal name
OXIRA XR AS
Org number
926419919
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
20. januar 2021
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene. Daglig leder alene.
Company purpose
Utvikling, produksjon og salg av byggematerialer.
Contact
Address
Isdamveien 24A, 3083 Holmestrand
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Holmestrand
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
373
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−7
−13
−4
−12
159
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−7
−13
−4
−12
159
Net financials
−0
0
−0
−1
0
Profit before tax
−7
−13
−4
−13
159
Tax
−0
−0
−0
−0
27
Net profit
−7
−13
−4
−13
132
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
22
21
20
0
463
Equity
23
10
5
−7
125
Long-term debt
0
0
0
0
0
Short-term debt
−1
11
15
7
338
Total debt
−1
11
15
7
338
Financial ratios
5-year trend
EBITDA margin
42.5%
This company
15.8%
Market median
+169% vs market
2021
2025
Equity ratio
26.9%
This company
38.2%
Market median
-30% vs market
2021
2025
Return on equity
105.6%
This company
18.4%
Market median
+474% vs market
2021
2025
Net profit margin
35.3%
This company
8.1%
Market median
+336% vs market
2021
2025
Asset turnover
0.81×
This company
1.12×
Market median
+28% vs market
2021
2025
Debt / equity
2.71×
This company
0.62×
Market median
-337% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-04 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
FE
Finn Erik Solvang
Chief Executive Officer
Chief Executive Officer
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
GS
Gunnar Sveinsbø
Board of Directors
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Lbg Invest As
Company
50%
50%
2024
Ophiolite As
Company
50%
50%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Sfactr As
Ophiolite As
OXIRA XR AS
(this company)
Board network connections
Board members of OXIRA XR AS also hold positions in
0
other companies.
Person
Role here
Other companies
Finn Erik Solvang
Chief Executive Officer
0 companies
Gunnar Sveinsbø
Board of Directors
0 companies